Tikun Olam-Cannbit Pharmaceuticals Ltd (TKUN.TA)
ILA 34.1
(-0.29%)
ILA 34.1
(-0.29%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 89.63 Million ILS | 105.42% |
| 2022 | 13 Million ILS | -33.48% |
| 2021 | 19.55 Million ILS | -38.32% |
| 2020 | 31.69 Million ILS | 230.82% |
| 2019 | 9.58 Million ILS | -53.08% |
| 2018 | 20.42 Million ILS | 4727.66% |
| 2017 | 423 Thousand ILS | 114.72% |
| 2016 | 197 Thousand ILS | -88.67% |
| 2015 | 1.73 Million ILS | -50.21% |
| 2014 | 3.49 Million ILS | -72.27% |
| 2013 | 12.58 Million ILS | -35.08% |
| 2012 | 19.38 Million ILS | 179.77% |
| 2011 | -24.3 Million ILS | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 14.53 Million ILS | 118.23% |
| 2024 Q2 | 14.53 Million ILS | 0.0% |
| 2023 Q4 | -79.75 Million ILS | -776.99% |
| 2023 FY | 26.71 Million ILS | 105.42% |
| 2023 Q2 | 39.82 Million ILA | 0.0% |
| 2023 Q3 | 11.78 Million ILS | -70.42% |
| 2023 Q1 | 39.82 Million ILS | 66.8% |
| 2022 Q2 | 8.9 Million ILA | 0.0% |
| 2022 Q4 | 23.87 Million ILA | 0.0% |
| 2022 FY | 13 Million ILS | -33.48% |
| 2022 Q1 | 8.9 Million ILS | 22.37% |
| 2022 Q3 | 23.87 Million ILS | 168.18% |
| 2021 Q2 | 12.92 Million ILS | 0.0% |
| 2021 Q1 | 12.92 Million ILS | -4.88% |
| 2021 FY | 19.55 Million ILS | -38.32% |
| 2021 Q3 | 7.27 Million ILS | -43.72% |
| 2021 Q4 | 7.27 Million ILS | 0.0% |
| 2020 Q4 | 13.59 Million ILS | 0.0% |
| 2020 FY | 31.69 Million ILS | 230.82% |
| 2020 Q2 | 10.49 Million ILS | 0.0% |
| 2020 Q3 | 13.59 Million ILS | 29.53% |
| 2020 Q1 | 10.49 Million ILS | 178.96% |
| 2019 Q1 | 1.56 Million ILS | -84.68% |
| 2019 Q2 | 1.56 Million ILS | 0.0% |
| 2019 FY | 9.58 Million ILS | -53.08% |
| 2019 Q3 | 3.76 Million ILS | 140.43% |
| 2019 Q4 | 3.76 Million ILS | 0.0% |
| 2018 Q2 | 176.5 Thousand ILS | 0.0% |
| 2018 Q4 | 10.21 Million ILS | 0.0% |
| 2018 Q3 | 10.21 Million ILS | 5687.54% |
| 2018 Q1 | 176.5 Thousand ILS | 0.0% |
| 2018 FY | 20.42 Million ILS | 4727.66% |
| 2017 FY | 423 Thousand ILS | 114.72% |
| 2016 Q4 | -675 Thousand ILS | -208.35% |
| 2016 Q3 | 623 Thousand ILS | 2325.0% |
| 2016 FY | 197 Thousand ILS | -88.67% |
| 2016 Q2 | -28 Thousand ILS | -110.11% |
| 2016 Q1 | 277 Thousand ILS | 194.54% |
| 2015 Q1 | 2.17 Million ILS | 113.54% |
| 2015 Q4 | -293 Thousand ILS | -137.76% |
| 2015 Q3 | 776 Thousand ILS | 184.26% |
| 2015 Q2 | -921 Thousand ILS | -142.33% |
| 2015 FY | 1.73 Million ILS | -50.21% |
| 2014 Q1 | 486 Thousand ILS | -80.72% |
| 2014 Q2 | 1.52 Million ILS | 214.61% |
| 2014 FY | 3.49 Million ILS | -72.27% |
| 2014 Q3 | 457 Thousand ILS | -70.11% |
| 2014 Q4 | 1.01 Million ILS | 122.98% |
| 2013 Q2 | 588 Thousand ILS | -95.24% |
| 2013 FY | 12.58 Million ILS | -35.08% |
| 2013 Q4 | 2.52 Million ILS | 225.29% |
| 2013 Q1 | 12.35 Million ILS | 0.0% |
| 2013 Q3 | 775 Thousand ILS | 31.8% |
| 2012 FY | 19.38 Million ILS | 179.77% |
| 2011 FY | -24.3 Million ILS | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Cannabotech LTD | 15.36 Million ILA | -483.251% |